CIT can broadcast your seminar, conference or meeting live to a world-wide
audience over the Internet as a real-time streaming video. The event can
be recorded and made available for viewers to watch at their convenience
as an on-demand video or a downloadable podcast. CIT can also broadcast
NIH-only or HHS-only content.
The U.S. Department of Health and Human Services (HHS) will host a three-hour educational program for the media to learn more about ongoing government research efforts to develop and apply new technologies in the making of seasonal and pandemic influenza vaccines. The flu vaccines we use today are extraordinarily safe and have helped protect millions against influenza, but current egg-based technologies are outdated. There are increasing opportunities for new technologies to help better meet both seasonal influenza vaccine and pandemic preparedness and response needs. In these sessions, attendees will hear from and be able to question a number of HHS’ top experts on current research efforts, advanced development support, and the regulatory science being applied to help transform vaccine technologies to support rapid, flexible and reliable approaches to influenza and other emerging threats.
Runtime:
02:25:06
NLM Title:
HHS science seminar for media : advances in influenza vaccine technologies [electronic resource] / HHS.
Series:
Advances in influenza vaccine technologies
Author:
United States. Department of Health and Human Services.
Publisher:
Other Title(s):
Advances in influenza vaccine technologies
Abstract:
(CIT): The U.S. Department of Health and Human Services (HHS) will host a three-hour educational program for the media to learn more about ongoing government research efforts to develop and apply new technologies in the making of seasonal and pandemic influenza vaccines. The flu vaccines we use today are extraordinarily safe and have helped protect millions against influenza, but current egg-based technologies are outdated. There are increasing opportunities for new technologies to help better meet both seasonal influenza vaccine and pandemic preparedness and response needs. In these sessions, attendees will hear from and be able to question a number of HHS' top experts on current research efforts, advanced development support, and the regulatory science being applied to help transform vaccine technologies to support rapid, flexible and reliable approaches to influenza and other emerging threats.
